MedTrace Logo

Safety and Efficacy Evaluation of the Mosaic Ultra Device

NCT06117293 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-11-07

No results posted yet for this study

Summary

Evaluate the Safety and Efficacy of the Mosaic Ultra 1550nm system for the treatment of skin tone and texture, facial rejuvenation, photoaging, wrinkles, scars, stretch marks, acne vulgaris and hair loss.

Conditions

  • Skin Texture Disorder
  • Photoaging
  • Wrinkle
  • Scar
  • Stretch Mark
  • Acne Vulgaris
  • Hair Loss

Interventions

DEVICE

Mosaic

1550 Fractional Laser System

Sponsors & Collaborators

  • LUTRONIC Corporation

    lead INDUSTRY

Principal Investigators

  • Omar Ibrahimi · Lutronic Medical Director

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-21
Primary Completion
2024-09-01
Completion
2025-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06117293 on ClinicalTrials.gov